Cost-Effectiveness Analysis of Patiromer in Combination with Renin–Angiotensin–Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden

Author:

Widén Julia,Ivarsson Magnus,Schalin Lovisa,Vrouchou Polina,Schwenkglenks Matthias,Heimbürger Olof,Ademi Zanfina,Sutherland C. Simone

Funder

Vifor Pharma

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Reference90 articles.

1. Mortality GBD, Causes of Death C, Wang H, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–544.

2. Rosenberg M. Overview of the management of chronic kidney disease in adults. UpToDate. 2019. https://www.uptodate.com/contents/overview-of-the-management-of-chronic-kidney-disease-in-adults. Accessed 03 Mar 2019.

3. European Dialysis and Transplant Association. Chronic kidney disease – a challenge for European Healthcare Systems. 2015. http://www.era-edta2015.org/press/1_150526_18.00_Press%20Release_CKD_Challenge.pdf. Accessed 05 Mar 2019.

4. Gasparini A, Evans M, Coresh J, et al. Prevalence and recognition of chronic kidney disease in Stockholm healthcare. Nephrol Dial Transplant. 2016;31:2086–94.

5. Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96:414-22D.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3